N Rajan

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. pmc Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours
    N Rajan
    Institute of Human Genetics, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
    Oncogene 30:4243-60. 2011

Collaborators

Detail Information

Publications1

  1. pmc Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours
    N Rajan
    Institute of Human Genetics, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
    Oncogene 30:4243-60. 2011
    ..These results suggest that TRK inhibition could be used as a strategy to treat tumours with loss of functional CYLD...